Cite
HARVARD Citation
Shovman, O. et al. (2019). Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib. Pharmacological research. pp. 623-626. [Online].